Multiple Manufacturers

RAPAMUNE

Manufacturer:

Multiple Manufacturers

Rapamune HCPCS:

J7520

HCPCS Code Descriptor:

Sirolimus, oral, 1 mg

Category:

J Code

Rapamune NDCs:

67877-0748-01, 59762-1205-06, 60505-6197-02, 68462-0683-01, 16714-0188-01, 00008-1040-05, 55111-0654-01, 59762-1003-01, 00008-1040-10, 00008-1030-06, 16714-0189-01, 68462-0684-01, 00008-1041-10, 00008-1041-05, 00008-1042-05, 50268-0718-13, 59762-1001-01, 68462-0682-01, 16714-0187-01, 67877-0746-01, 67877-0747-01, 59762-1002-01, 55111-0653-01

Primary Type:

Immunosuppressant

Generic/Specialty Status:

Multi-Source

Package Type:

Not Found

Route of Administration:

Oral

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Rapamune:

RAPAMUNE is a medication manufactured by multiple manufacturers and aligned to the J Code: J7520. RAPAMUNE is administered via the oral route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J7520 Added Date:

January 1, 2001

J7520 Effective Date:

January 1, 2001

J7520 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Rapamune billing and coding information.
Rapamune patient assistance information can be found through Pfizer Rx Pathways at the URL: http://www.pfizerrxpathways.com/
RAPAMUNE prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for RAPAMUNE. Please check back in a few weeks.